Grant: Doctoral: Vanier Canada Graduate Scholarships
McGill University
$20,833.00
Application of the molecular understanding of high density lipoprotein biogenesis to provide surrogate endpoints for use in an atherosclerosis therapy study
FY 2008-09
Summary
Cardiovascular disease remains the number one cause of death worldwide. High density lipoprotein (HDL) particles, often referred to as "good cholesterol", are believed to protect against cardiovascular disease by several mechanisms. For the past 18 years, our laboratory has been investigating the genetic basis of HDL deficiency and the molecular basis of HDL formation. We believe that by understanding how HDL is formed, we can understand how it protects against atherosclerosis. Specifically, our goals are to determine what HDL is composed of, how cells orchestrate HDL synthesis, and how different types of HDL (e.g. newly synthesized, small, large, etc.) differ in their functional properties. To accomplish these goals, we will collaborate with researchers at Harvard Medical School, the McGill University and Genome Quebec Innovation Center, and the University of Milan. Once we have met these goals, we will apply our understanding to evaluate a novel HDL-raising compound, RVX-208, in treating and preventing atherosclerosis. We hope to provide conceptual and molecular basis for this novel therapy.
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
184571
Name
Bailey Dana
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Application of the molecular understanding of high density lipoprotein biogenesis to provide surrogate endpoints for use in an atherosclerosis therapy study
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$20,833
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
2d Pagge; Abc Transporters; Animal Study/Rabbit Model; Atherosclerosis; Cell Culture; Cell Signaling Pathways; Cellular Cholesterol Efflux; Hdl Remodeling And Metabolism; High Density Lipoprotein (Hdl); Therapeutic/Clinical Potential
Abstract
Cardiovascular disease remains the number one cause of death worldwide. High density lipoprotein (HDL) particles, often referred to as "good cholesterol", are believed to protect against cardiovascular disease by several mechanisms. For the past 18 years, our laboratory has been investigating the genetic basis of HDL deficiency and the molecular basis of HDL formation. We believe that by understanding how HDL is formed, we can understand how it protects against atherosclerosis. Specifically, our goals are to determine what HDL is composed of, how cells orchestrate HDL synthesis, and how different types of HDL (e.g. newly synthesized, small, large, etc.) differ in their functional properties. To accomplish these goals, we will collaborate with researchers at Harvard Medical School, the McGill University and Genome Quebec Innovation Center, and the University of Milan. Once we have met these goals, we will apply our understanding to evaluate a novel HDL-raising compound, RVX-208, in treating and preventing atherosclerosis. We hope to provide conceptual and molecular basis for this novel therapy.
Competitiondate
200811
Approvedterm2
0 yr 5 mths
Pinamesdelim
Bailey, Dana
Approvedterm
0 an 5 mois
Cihrcontribution2
~ $20,833~ $0~